Strive Financial Group »

Context Therapeutics shares owned by Strive Financial Group

Quarter-by-quarter ownership of Context Therapeutics (CNTX) shares owned by Strive Financial Group from 13F filings

Historical chart of Strive Financial Group investment in Context Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Context Therapeutics held by Strive Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Context Therapeutics by Strive Financial Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $4.0k 1.7k 2.35
2025-12-31 $2.5k 1.7k 1.47

More positions owned by Strive Financial Group

Call Nvidia Corp $150 Exp 05/15/26 Option Equity Call Option (NVDA)
Call Eli Lilly And Co $800 Exp 05/15/26 Option Equity Call Option (LLY)
Call Alphabet Inc $315 Exp 05/15/26 Option Equity Call Option (GOOG)
Call Taiwan Semiconducto$270 Exp 07/17/26 Option Equity Call Option (TSM)
Vanguard S&p 500 Etf Uit Exchange Traded (VOO)
Ishares Core Msci Eafe Etf Uit Exchange Traded (IEFA)
Vanguard Mid-cap Index Fund Etf Shares Uit Exchange Traded (VO)
Call Amazon.com Inc $217.5 Exp 04/17/26 Option Equity Call Option (AMZN)
Apple Common Stock (AAPL)
Call C H Robinson Worldw$135 Exp 08/21/26 Option Equity Call Option (CHRW)
Meta Platforms Inc Class Class A Common Stock (META)
Alphabet Inc Class Class A Common Stock (GOOGL)
Call The Coca-cola Co $70 Exp 04/17/26 Option Equity Call Option (KO)
Ishares Core U.s. Aggregate Bond Etf Uit Exchange Traded (AGG)
Call Donaldson Inc $80 Exp 05/15/26 Option Equity Call Option (DCI)

View all positions for Strive Financial Group

Top funds holding Context Therapeutics

MPM Oncology Impact Management
Blue Owl Capital Holdings
Nextech Invest
Deep Track Capital
Soleus Capital Management
Octagon Capital Advisors
Avidity Partners Management
Franklin Resources
Vanguard Group
Vanguard Capital Management
TCG Crossover Management
Marshall Wace
Dr. Jeffrey R. Jay, M.D.
Millennium Management
Sio Capital Management

View all funds holding Context Therapeutics